Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Women encounter ADRs more often than do men

Zopf, Y., Rabe, C., Neubert, A., Gaßmann, K. G., Rascher, W., Hahn, E. G., Brune, K., Dormann, H. · 2008 · European Journal of Clinical Pharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00228-008-0494-6

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 44

  1. Bowman L, Carlstedt BC, Hancock EF, Black CD (1996) Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients. Pharmacoepidemiol Drug Saf 5:9–18 · doi:10.1002/(sici)1099-1557(199601)5:1<9::aid-pds192>3.0.co;2-2
  2. Caamano F, Pedone C, Zuccala G, Carbonin P (2005) Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. Arch Gerontol Geriatr 40:45–52 · doi:10.1016/j.archger.2004.05.005
  3. Camargo AL, Cardoso Ferreira MB, Heineck I (2006) Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 62:143–149 · DOI
  4. Carbonin P, Pahor M, Bernabei R, Sgadari A (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39:1093–1099 · DOI · Paper page
  5. Gonzalez-Martin G, Yanez CG, Gonzalez-Contreras L, Labarca J (1999) Adverse drug reactions (ADRs) in patients with HIV infection, A prospective study. Int J Clin Pharmacol Ther 37:34–40
  6. Hoigne R, Sollberger J, Zoppi M, Muller U, Hess T, Fritschy D, Stocker F, Maibach R (1984) [Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)]. Schweiz Med Wochenschr 114:1854–1857
  7. Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962–1968 · DOI · Paper page
  8. Tran C, Knowles SR, Liu BA, Shear NH (1998) Gender differences in adverse drug reactions. J Clin Pharmacol 38:1003–1009 · DOI · Paper page
  9. van den Bemt PM, Egberts AC, Lenderink AW, Verzijl JM, Simons KA, van der Pol WS, Leufkens HG (2000) Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 22:62–66 · DOI
  10. Aros CA, Ardiles LG, Schneider HO, Flores CA, Alruiz PA, Jerez VR, Mezzano SA (2005) No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem. Transplant Proc 37:3364–3366 · doi:10.1016/j.transproceed.2005.09.098
  11. Trifiro G, Calogero G, Ippolito FM, Cosentino M, Giuliani R, Conforti A, Venegoni M, Mazzaglia G, Caputi AP (2005) Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf 14(5):333–340 · DOI
  12. Schwartz JB (2003) The influence of sex on pharmacokinetics. Clin Pharmacokinet 42:107–121 · DOI · Paper page
  13. Kashuba AD, Nafziger AN (1998) Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinet 34:203–218 · DOI · Paper page
  14. Anderson GD (2005) Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 14:19–29 · DOI · Paper page
  15. Tanaka E (1999) Gender-related differences in pharmacokinetics and their clinical significance. Clin Pharm Ther 24:339–346 · DOI · Paper page
  16. Zhu Y, Statkevich P, Curtis D, Cutler DL, Zhang M, Richards W (2004) Effects of age and gender on the pharmacokinetics of lonafarnib (L) following a single oral dose. Clin Pharm Ther 75:P59
  17. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259 · DOI · Paper page
  18. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tageder I, Schneider HT, Hahn EG, Levy M, Brune K, Geisslinger G (2000) Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 22:161–168 · DOI · Paper page
  19. Gray SL, Mahoney JE, Blough DK (1999) Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 33:1147–1153 · DOI
  20. Beierle I, Meibohm B, Derendorf H (1999) Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther 37:529–547
  21. Franconi F, Brunelleschi S, Steardo L, Cuomo V (2007) Gender differences in drug responses. Pharmacol Res 55:81–95 · DOI · Paper page
  22. Kando JC, Yonkers KA, Cole JO (1995) Gender as a risk factor for adverse events to medications. Drugs 50:1–6 · DOI
  23. Krecic-Shepard ME, Barnas CR, Slimko J, Jones MP, Schwartz JB (2000) Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol 40:219–230 · DOI
  24. Passarelli MC, Jacob-Filho W, Figueras A (2005) Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 22:767–777 · DOI · Paper page
  25. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, Petersen LA, Small SD, Sweitzer BJ, Vander Vliet M, Leape LL (1999) Patient risk factors for adverse drug events in hospitalized patients ADE Prevention Study Group. Arch Intern Med 159:2553–2560 · DOI · Paper page
  26. Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G (1997) Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res 35:85–88 · DOI
  27. Gurwitz JH, Avorn J (1990) Old age–is it a risk for adverse drug reactions? Agents Actions (Suppl) 29:13–25
  28. Vakil BJ, Kulkarni RD, Chabria NL, Chadha DR, Deshpande VA (1975) Intense surveillance of adverse drug reactionsAn analysis of 338 patients. J Clin Pharmacol 15:435–441 · doi:10.1002/j.1552-4604.1975.tb02365.x
  29. Atkin PA, Veitch PC, Veitch EM, Ogle SJ (1999) The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging 14:141–152 · DOI · Paper page
  30. Schwartz JB (2007) The current state of knowledge on age, sex, and their interaction on clinial pharmacology. Clin Pharmacol Ther 82:87–96 · DOI · Paper page
  31. Harris RZ, Benet LZ, Schwartz JB (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222–239 · DOI · Paper page
  32. Hunt CM, Westerkam WR, Stave GM (1992) Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 44:275–283 · DOI · Paper page
  33. Rademaker M (2001) Do women have more adverse drug reactions? Am J Clin Dermatol 2:349–351 · DOI · Paper page
  34. Bebia Z, Buch SC, Wilson JW, Frye RF, Romkes M, Cecchetti A, Chaves-Gnecco D, Branch RA (2004) Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol Ther 76:618–627 · DOI
  35. Laine K, Tybring G, Bertilsson L (2000) No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects. Clin Pharmacol Ther 68:151–159 · DOI
  36. Wilkinson GR, Guengerich FP, Branch RA (1989) Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther 43:53–76 · DOI · Paper page
  37. Hagg S, Spigset O, Dahlqvist R (2001) Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers. Br J Clin Pharmacol 51:169–173 · doi:10.1111/j.1365-2125.2001.01328.x · Paper page
  38. Gleiter CH, Gundert-Remy U (1996) Gender differences in pharmacokinetics. Eur J Drug Metab Pharmacokinet 21:123–128 · DOI
  39. Drici MD, Clement N (2001) Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 24:575–585 · DOI · Paper page
  40. Wolbrette DL (2003) Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol 91:39D–44D · DOI
  41. Wolbrette D (2002) Gender differences in the proarrhythmic potential of QT-prolonging drugs. Curr Womens Health Rep 2:105–109
  42. Peters RW, Gold MR (2004) The influence of gender on arrhythmias. Cardiol Rev 12:97–105 · DOI
  43. Galatti L, Giustini SE, Sessa A, Polimeni G, Salvo F, Spina E, Caputi AP (2005) Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy. Pharmacol Res 51:211–216 · DOI
  44. Domecq C, Naranjo CA, Ruiz I, Busto U (1980) Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol Ther Toxicol 18:362–366

Cited by

See all 200

Metadata

Authors
Zopf, Y., Rabe, C., Neubert, A., Gaßmann, K. G., Rascher, W., Hahn, E. G., Brune, K., & Dormann, H.
Venue
European Journal of Clinical Pharmacology
Published
2008-07-05
Volume
64
Issue
10
Pages
999-1004
ISSN
  • 0031-6970
  • 1432-1041
Cited by
200
References
2
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Women encounter ADRs more often than do men. https://app.cochat.ai/papers/10.1007/s00228-008-0494-6
The paper
Zopf, Y., Rabe, C., Neubert, A., Gaßmann, K. G., Rascher, W., Hahn, E. G., Brune, K., & Dormann, H. (2008). Women encounter ADRs more often than do men. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-008-0494-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.